GLP-1
Glucagon-Like Peptide-1, a gut hormone family targeted by drugs like Ozempic and Mounjaro that affect appetite, metabolism, the brain, and inflammation.
As defined in How to Be a Super Ager (with Eric Topol)
Where it comes up · 28
- What is GLP-1 & How Does It Reduce Appetite & Promote Weight Loss? | Dr. Andrew Huberman10 claims
- Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]8 claims
- Dr Jason Fung’s BRUTALLY Honest Opinion On OZEMPIC!5 claims
- RTW: Investing Across Healthcare4 claims
- Zach Reitano - Building Ro and Why Healthcare Should Be 50% of GDP - [Invest Like the Best, EP.500]4 claims
- Business, Culture, and Content3 claims
- Intuitive Surgical: Robotic Precision3 claims
- How to Be a Super Ager (with Eric Topol)3 claims
and 20 more
Most important claims · 10 of 69Search all claims for “GLP-1” →
- The body's naturally produced GLP-1 hormone lasts only about two minutes, so using it directly would require about 30 injections an hour; molecular engineering extended it to a weekly or daily dosing schedule.Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]
- Weight loss is fundamentally about controlling hunger through hormonal signals, not about controlling calorie intake, because GLP-1 drugs don't burn any calories yet still produce significant weight lossDr Jason Fung’s BRUTALLY Honest Opinion On OZEMPIC!
- The paper 'An inter-organ neural circuit for appetite suppression' published in Cell journal demonstrates that GLP-1 suppresses appetite through at least two independent parallel mechanisms: one via intestinofugal enteric neurons causing gut distension, and another via neural communication to the hypothalamus that triggers satiety.What is GLP-1 & How Does It Reduce Appetite & Promote Weight Loss? | Dr. Andrew Huberman
- GLP-1 drugs like Ozempic and Zepbound reduce appetite significantly and cause sustained weight loss by activating the satiety signal in the brain, even when no food has been consumedDr Jason Fung’s BRUTALLY Honest Opinion On OZEMPIC!
- GLP-1 slows stomach emptying, signals satiety in the brain to quiet food noise, and triggers insulin release from the pancreas, producing effects that span diabetes, cardiovascular, kidney, and inflammation benefits.Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]
- At identical doses of the same GLP-1 drug, people with Type 2 diabetes lose only a few pounds while people with obesity can lose 30 to 60 pounds, and the reason for this dramatic difference remains unknown—an example of how much we still do not understand about these drugs.How to Be a Super Ager (with Eric Topol)
- GLP-1s are approved for diabetes, obesity, heart disease, liver disease, kidney disease, and sleep apnea, conditions upstream of the leading causes of death, so their individual health impact is tremendous, having expanded from only diabetes four years ago.Zach Reitano - Building Ro and Why Healthcare Should Be 50% of GDP - [Invest Like the Best, EP.500]
- GLP-1s carry real toxicity, including nausea, vomiting, diarrhea, gallstones, pancreatitis, and muscle loss, but the speaker judges the cardiometabolic and lifespan benefits worth the risk, with obesity-related diseases costing five to ten years of life.Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]
- GLP-1 suppresses appetite through a second mechanism by which intestinofugal enteric neurons communicate to the hypothalamus via the sympatho-gastro-spinal-reticular-hypothalamic pathway, activating neural pathways that trigger satiety (the feeling of having had enough food).What is GLP-1 & How Does It Reduce Appetite & Promote Weight Loss? | Dr. Andrew Huberman
- GLP-1 acts on intestinofugal enteric neurons in the enteric nervous system, which are part of the autonomic nervous system that operates without conscious control.What is GLP-1 & How Does It Reduce Appetite & Promote Weight Loss? | Dr. Andrew Huberman